tiprankstipranks

VWUSX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

VWUSX Analyst Rating

Moderate Buy
115ConsensusRatings
103 Buy
10 Hold
2 Sell
Based on the consensus analyst ratings on 115 stocks held in VWUSX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VWUSX Analyst Price Target

Average Price Target

$72.48
Based on 115 Wall Street analysts offering 12 month price targets to Vanguard U.S. Growth Fund holdings in the last 3 months. The average price target is $72.48 with a high forecast of $86.53 and a low forecast of $57.25. The average price target represents a 15.73% change from the last price of $62.63.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"43":"$43","54":"$54","65":"$65","76":"$76","87":"$87"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":86.527,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$86.53</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72.48,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$72.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":57.249,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$57.25</span>\n  </div></div>","useHTML":true}}],"tickPositions":[43,54,65,76,87],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.42,62.42823076923077,64.43646153846154,66.4446923076923,68.45292307692307,70.46115384615385,72.46938461538461,74.47761538461539,76.48584615384615,78.49407692307693,80.5023076923077,82.51053846153846,84.51876923076924,{"y":86.527,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.42,61.34769230769231,62.27538461538462,63.20307692307693,64.13076923076923,65.05846153846154,65.98615384615385,66.91384615384615,67.84153846153846,68.76923076923077,69.69692307692308,70.62461538461538,71.55230769230769,{"y":72.48,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.42,60.17607692307693,59.932153846153845,59.68823076923077,59.444307692307696,59.200384615384614,58.95646153846154,58.712538461538465,58.46861538461539,58.22469230769231,57.98076923076923,57.73684615384616,57.49292307692308,{"y":57.249,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":44.96,"date":1682899200000,"info":"<div>Price: <b>$45<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":48.64,"date":1685577600000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":51.2,"date":1688342400000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.91,"date":1690848000000,"info":"<div>Price: <b>$53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.17,"date":1693526400000,"info":"<div>Price: <b>$52<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":49.42,"date":1696204800000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":48.22,"date":1698796800000,"info":"<div>Price: <b>$48<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":54.18,"date":1701388800000,"info":"<div>Price: <b>$54<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.51,"date":1704153600000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.85,"date":1706745600000,"info":"<div>Price: <b>$59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.41,"date":1709251200000,"info":"<div>Price: <b>$63<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.54,"date":1711929600000,"info":"<div>Price: <b>$64<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":60.42,"date":1714521600000,"info":"<div>Price: <b>$60<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$86.53Average Price Target$72.48Lowest Price Target$57.25
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VWUSX Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Denali Therapeutics
12 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Ginkgo Bioworks Holdings, Inc.
1 Buy
2 Hold
1 Sell
Hold
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Guardant Health
11 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Recursion Pharmaceuticals, Inc
1 Buy
2 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Coursera Inc
9 Buy
1 Hold
1 Sell
Moderate Buy

VWUSX Stocks With Highest Downside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Airbus Se (OTC)
0 Buy
0 Hold
1 Sell
Moderate Sell
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Watsco Inc
2 Buy
4 Hold
1 Sell
Hold
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Mettler-toledo International
1 Buy
1 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
American Express Company
10 Buy
7 Hold
3 Sell
Moderate Buy
xxxxxxxxxxxxxxxxxxxxxxxxxxx
L'Oreal S.A. (UK)
7 Buy
2 Hold
3 Sell
Moderate Buy

VWUSX Mutual Fund FAQ

What is VWUSX’s average 12-month price target, according to analysts?
Based on analyst ratings, Vanguard U.S. Growth Fund’s 12-month average price target is $72.48.
    What is VWUSX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for VWUSX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is VWUSX a Buy, Sell or Hold?
        Vanguard U.S. Growth Fund has a conensus rating of Moderate Buy which is based on 103 buy ratings, 10 hold ratings and 2 sell ratings.
          What is Vanguard U.S. Growth Fund’s price target?
          The average price target for Vanguard U.S. Growth Fund is $72.48. This is based on 115 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $86.53 ,the lowest forecast is $57.25. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about Vanguard U.S. Growth Fund?
            Vanguard U.S. Growth Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 115 Wall Streets Analysts.
              How can I buy shares of VWUSX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis